Researcher profile

Evangelia Kyrimi

Evangelia Kyrimi contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
7works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2022arXiv

The Self-Driving Car: Crossroads at the Bleeding Edge of Artificial Intelligence and Law

Artificial intelligence (AI) features are increasingly being embedded in cars and are central to the operation of self-driving cars (SDC). There is little or no effort expended towards understanding and assessing the broad legal and regulatory impact of the decisions made by AI in cars. A comprehensive literature review was conducted to determine the perceived barriers, benefits and facilitating factors of SDC in order to help us understand the suitability and limitations of existing and proposed law and regulation. (1) existing and proposed laws are largely based on claimed benefits of SDV that are still mostly speculative and untested; (2) while publicly presented as issues of assigning blame and identifying who pays where the SDC is involved in an accident, the barriers broadly intersect with almost every area of society, laws and regulations; and (3) new law and regulation are most frequently identified as the primary factor for enabling SDC. Research on assessing the impact of AI in SDC needs to be broadened beyond negligence and liability to encompass barriers, benefits and facilitating factors identified in this paper. Results of this paper are significant in that they point to the need for deeper comprehension of the broad impact of all existing law and regulations on the introduction of SDC technology, with a focus on identifying only those areas truly requiring ongoing legislative attention.

preprint2020arXiv

A Comprehensive Scoping Review of Bayesian Networks in Healthcare: Past, Present and Future

No comprehensive review of Bayesian networks (BNs) in healthcare has been published in the past, making it difficult to organize the research contributions in the present and identify challenges and neglected areas that need to be addressed in the future. This unique and novel scoping review of BNs in healthcare provides an analytical framework for comprehensively characterizing the domain and its current state. The review shows that: (1) BNs in healthcare are not used to their full potential; (2) a generic BN development process is lacking; (3) limitations exists in the way BNs in healthcare are presented in the literature, which impacts understanding, consensus towards systematic methodologies, practice and adoption of BNs; and (4) a gap exists between having an accurate BN and a useful BN that impacts clinical practice. This review empowers researchers and clinicians with an analytical framework and findings that will enable understanding of the need to address the problems of restricted aims of BNs, ad hoc BN development methods, and the lack of BN adoption in practice. To map the way forward, the paper proposes future research directions and makes recommendations regarding BN development methods and adoption in practice.

preprint2020arXiv

An Incremental Explanation of Inference in Hybrid Bayesian Networks for Increasing Model Trustworthiness and Supporting Clinical Decision Making

Various AI models are increasingly being considered as part of clinical decision-support tools. However, the trustworthiness of such models is rarely considered. Clinicians are more likely to use a model if they can understand and trust its predictions. Key to this is if its underlying reasoning can be explained. A Bayesian network (BN) model has the advantage that it is not a black-box and its reasoning can be explained. In this paper, we propose an incremental explanation of inference that can be applied to hybrid BNs, i.e. those that contain both discrete and continuous nodes. The key questions that we answer are: (1) which important evidence supports or contradicts the prediction, and (2) through which intermediate variables does the information flow. The explanation is illustrated using a real clinical case study. A small evaluation study is also conducted.

preprint2020arXiv

Bayesian Networks in Healthcare: Distribution by Medical Condition

Bayesian networks (BNs) have received increasing research attention that is not matched by adoption in practice and yet have potential to significantly benefit healthcare. Hitherto, research works have not investigated the types of medical conditions being modelled with BNs, nor whether any differences exist in how and why they are applied to different conditions. This research seeks to identify and quantify the range of medical conditions for which healthcare-related BN models have been proposed, and the differences in approach between the most common medical conditions to which they have been applied. We found that almost two-thirds of all healthcare BNs are focused on four conditions: cardiac, cancer, psychological and lung disorders. We believe that a lack of understanding regarding how BNs work and what they are capable of exists, and that it is only with greater understanding and promotion that we may ever realise the full potential of BNs to effect positive change in daily healthcare practice.

preprint2020arXiv

Bluetooth Smartphone Apps: Are they the most private and effective solution for COVID-19 contact tracing?

Many digital solutions mainly involving Bluetooth technology are being proposed for Contact Tracing Apps (CTA) to reduce the spread of COVID-19. Concerns have been raised regarding privacy, consent, uptake required in a given population, and the degree to which use of CTAs can impact individual behaviours. However, very few groups have taken a holistic approach and presented a combined solution. None has presented their CTA in such a way as to ensure that even the most suggestible member of our community does not become complacent and assume that CTA operates as an invisible shield, making us and our families impenetrable or immune to the disease. We propose to build on some of the digital solutions already under development that, with addition of a Bayesian model that predicts likelihood for infection supplemented by traditional symptom and contact tracing, that can enable us to reach 90% of a population. When combined with an effective communication strategy and social distancing, we believe solutions like the one proposed here can have a very beneficial effect on containing the spread of this pandemic.

preprint2020arXiv

Medical idioms for clinical Bayesian network development

Bayesian Networks (BNs) are graphical probabilistic models that have proven popular in medical applications. While numerous medical BNs have been published, most are presented fait accompli without explanation of how the network structure was developed or justification of why it represents the correct structure for the given medical application. This means that the process of building medical BNs from experts is typically ad hoc and offers little opportunity for methodological improvement. This paper proposes generally applicable and reusable medical reasoning patterns to aid those developing medical BNs. The proposed method complements and extends the idiom-based approach introduced by Neil, Fenton, and Nielsen in 2000. We propose instances of their generic idioms that are specific to medical BNs. We refer to the proposed medical reasoning patterns as medical idioms. In addition, we extend the use of idioms to represent interventional and counterfactual reasoning. We believe that the proposed medical idioms are logical reasoning patterns that can be combined, reused and applied generically to help develop medical BNs. All proposed medical idioms have been illustrated using medical examples on coronary artery disease. The method has also been applied to other ongoing BNs being developed with medical experts. Finally, we show that applying the proposed medical idioms to published BN models results in models with a clearer structure.

preprint2020arXiv

Public Authorities as Defendants: Using Bayesian Networks to determine the Likelihood of Success for Negligence claims in the wake of Oakden

Several countries are currently investigating issues of neglect, poor quality care and abuse in the aged care sector. In most cases it is the State who license and monitor aged care providers, which frequently introduces a serious conflict of interest because the State also operate many of the facilities where our most vulnerable peoples are cared for. Where issues are raised with the standard of care being provided, the State are seen by many as a deep-pockets defendant and become the target of high-value lawsuits. This paper draws on cases and circumstances from one jurisdiction based on the English legal tradition, Australia, and proposes a Bayesian solution capable of determining probability for success for citizen plaintiffs who bring negligence claims against a public authority defendant. Use of a Bayesian network trained on case audit data shows that even when the plaintiff case meets all requirements for a successful negligence litigation, success is not often assured. Only in around one-fifth of these cases does the plaintiff succeed against a public authority as defendant.